Applying Science: Opportunities to Inform Disease Management Policy with Cooperative Research within a One Health Framework

Frontiers in Public Health
Jason K BlackburnJeanne Marie Fair

Abstract

The ongoing Ebola outbreak in West Africa and the current saiga antelope die off in Kazakhstan each represent very real and difficult to manage public or veterinary health crises. They also illustrate the importance of stable and funded surveillance and sound policy for intervention or disease control. While these two events highlight extreme cases of infectious disease (Ebola) or (possible) environmental exposure (saiga), diseases such as anthrax, brucellosis, tularemia, and plague are all zoonoses that pose risks and present surveillance challenges at the wildlife-livestock-human interfaces. These four diseases are also considered important actors in the threat of biological terror activities and have a long history as legacy biowarfare pathogens. This paper reviews recent studies done cooperatively between American and institutions within nations of the Former Soviet Union (FSU) focused on spatiotemporal, epidemiological, and ecological patterns of these four zoonoses. We examine recent studies and discuss the possible ways in which techniques, including ecological niche modeling, disease risk modeling, and spatiotemporal cluster analysis, can inform disease surveillance, control efforts, and impact policy. Our focus is to p...Continue Reading

References

Sep 4, 1999·Journal of Applied Microbiology·M Hugh-Jones
Sep 4, 1999·Journal of Applied Microbiology·B L Cherkasskiy
Sep 4, 1999·Journal of Applied Microbiology·A J TurnerG T Miller
Sep 4, 1999·Journal of Applied Microbiology·D C DragonT R Ellsworth
Apr 27, 2002·Revue Scientifique Et Technique·M E Hugh-Jones, V de Vos
Oct 9, 2004·Annual Review of Entomology·Kenneth L Gage, Michael Y Kosoy
Jan 28, 2006·The Lancet Infectious Diseases·Georgios PappasEpameinondas V Tsianos
Feb 21, 2006·Emerging Infectious Diseases·Zülal OzkurtSerhat F Ozyurek
Jul 14, 2006·Emerging Infectious Diseases·J Erin StaplesJeannine M Petersen
Mar 31, 2007·Annals of the New York Academy of Sciences·Anders Sjöstedt
Jul 17, 2009·Veterinary Microbiology·Mohamed N SeleemNammalwar Sriranganathan
Sep 15, 2009·Veterinary Microbiology·Antonio FasanellaMartin Hugh Jones
Apr 23, 2010·Emerging Infectious Diseases·Alim M AikembayevTed Hadfield
Dec 14, 2011·BMC Ecology·Jocelyn MullinsJason K Blackburn
Jul 21, 2012·Epidemiology and Infection·A FasanellaM Hugh-Jones
Dec 4, 2012·Vector Borne and Zoonotic Diseases·Kathleen A AlexanderJason K Blackburn
Jan 5, 2013·Preventive Veterinary Medicine·Eliso MamisashviliJason K Blackburn
Jun 20, 2013·Journal of Wildlife Diseases·Jason K Blackburn, Douglas G Goodin
Aug 24, 2013·Emerging Infectious Diseases·Saber EsamaeiliEhsan Mostafavi
Jan 23, 2014·Emerging Infectious Diseases·Ian KracalikJason K Blackburn
Jul 9, 2014·Lancet·Rashid AnsumanaKathryn H Jacobsen
Jul 18, 2014·PLoS Neglected Tropical Diseases·Ian KracalikJason K Blackburn
Jul 30, 2014·Vector Borne and Zoonotic Diseases·Jason K BlackburnValeriy Skrypnyk
Jul 30, 2014·Vector Borne and Zoonotic Diseases·Karoun H BagamianJason K Blackburn
Aug 21, 2014·The New England Journal of Medicine·Thomas R FriedenStuart Nichol

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Related Concepts

Related Feeds

Anthrax

Anthrax toxin, comprising protective antigen, lethal factor, and oedema factor, is the major virulence factor of Bacillus anthracis, an agent that causes high mortality in humans and animals. Here is the latest research on Anthrax.

Anthrax Vaccines

Three different types of anthrax vaccines are available; a live-attenuated, an alum-precipitated cell-free filtrate and a protein recombinant vaccine. The effectiveness between the three is uncertain, but the live-attenuated have shown to reduce the risk of anthrax with low adverse events. Here is the latest research on anthrax vaccines.

Brucellosis (ASM)

Brucellosis is a bacterial infection caused by members of the genus brucella and remains one of the world's major zoonotic diseases. Discover the latest research on Brucellosis here.

Anthrax Vaccines (ASM)

Three different types of anthrax vaccines are available; a live-attenuated, an alum-precipitated cell-free filtrate and a protein recombinant vaccine. The effectiveness between the three is uncertain, but the live-attenuated have shown to reduce the risk of anthrax with low adverse events. Here is the latest research on anthrax vaccines.

Brucellosis

Brucellosis is a bacterial infection caused by members of the genus brucella and remains one of the world's major zoonotic diseases. Discover the latest research on Brucellosis here.